Recro Pharma, Inc. i-capital capital
Utshintsho kwi-capitalisation yentengiso ye Recro Pharma, Inc. iwebhusayithi yethu ibamba kanye ngosuku. Inani lilonke Recro Pharma, Inc. Izicatshulwa zesitokhwe ezikhutshiweyo namhlanje yimali eyinkunzi Recro Pharma, Inc. isicatshulwa esitokhwe. Ngokusekwe kurhwebo lwexabiso lesitokhwe Recro Pharma, Inc. kwintengiso yokuthengiselana ngesitokhwe, unokuvavanya ubupapasho be- Recro Pharma, Inc.. Recro Pharma, Inc. i-capitalisation yehle nge- $ -1 468 984.
Recro Pharma, Inc. ivolumu yezorhwebo
Recro Pharma, Inc. umthamo wokurhweba namhlanje = 0 iidola zaseMelika. Recro Pharma, Inc. ithengiswa kwiiwebhusayithi ezahlukeneyo zorhwebo. Recro Pharma, Inc. yokuthengisa ngexesha lokwenyani elibanjwe kuninzi lokushintshiselana ngexabiso lesitoko, iwebhusayithi yethu ibonisa umthamo wemihla ngemihla wokurhweba Recro Pharma, Inc.. Recro Pharma, Inc. ikhonkco yentengiso yehla.
|
Recro Pharma, Inc. istatshi yekhredithi yemakethe
Recro Pharma, Inc. capitalisation kwigrafu ngeminyaka. -14.74% - utshintsho olwenziwayo kwi-capital capital ye Recro Pharma, Inc. ngeveki. 0% - Recro Pharma, Inc. utshintsho lwemalike lonyaka. Namhlanje, Recro Pharma, Inc. capitalization iqikelelwa 89 373 976 iidola zaseMelika.
| Iveki | Inyanga | iinyanga 3 | Unyaka | Iminyaka emithathu |
Recro Pharma, Inc. imbali yenkxaso-mali
| Umhla |
Ixabiso
Imali-mali (intengo-mali yemarike) yixabiso lemarike yazo zonke izabelo zeenkampani ezithengiswa kwi-stock exchange. Imali yentengo yemali ilingana nexabiso lezabelo ezandisiwe ngenani lezabelo ezikhoyo.
|
|---|---|
| 31/03/2022 | 89 373 976 € |
| 30/03/2022 | 90 842 960 € |
| 29/03/2022 | 94 575 192 € |
| 28/03/2022 | 96 867 928 € |
| 25/03/2022 | 97 345 016 € |
| 24/03/2022 | 96 629 808 € |
| 23/03/2022 | 104 829 728 € |
Recro Pharma, Inc. isatifiketi somqulu
| Iveki | Inyanga | iinyanga 3 | Unyaka | Iminyaka emithathu |
Recro Pharma, Inc. idatha yembali yevolumu
| Umhla |
Umqulu (24h)
Ixabiso lezorhwebo leRecro Pharma, Inc. izabelo yintlawulo yenani lazo zonke iintengiso kunye neengxenye ze-RAH.SG ezithengiweyo kwaye zathengiswa ngexesha lomhla okhethiweyo.
|
|---|---|
| 31/03/2022 | 0 € |
| 30/03/2022 | 0 € |
| 29/03/2022 | 0 € |
| 28/03/2022 | 0 € |
| 25/03/2022 | 0 € |
| 24/03/2022 | 0 € |
| 23/03/2022 | 0 € |
Recro Pharma, Inc. i-capitalisation yentengiso kwi 31/03/2022 ilingana ne 89 373 976 iidola zaseMelika. 30/03/2022 Recro Pharma, Inc. capitalisation ilingana 90 842 960 iidola zaseMelika. Vuliwe 29/03/2022, Recro Pharma, Inc. capitalisation yayiyi- $ 94 575 192. Recro Pharma, Inc. capitalization e 28/03/2022 ilingana ne 96 867 928 iidola zaseMelika.
Iimali yentengiso enkulu ye Recro Pharma, Inc. ifikelele kwi 97 345 016 Iidola zaseMelika ku- 25/03/2022. Recro Pharma, Inc. capitalised eyi- 96 629 808 Iidola zaseMelika ku- 24/03/2022. Recro Pharma, Inc. capitalization ilingane 104 829 728 Iidola zaseMelika ku- 23/03/2022.
Inkcitho ye-Recro Pharma, Inc. namhlanje ngu-89 373 976 €. Iimali zentengiso ye-Recro Pharma, Inc. ishintshile -1.617% xa kuthelekiswa nezolo. Imali yokuthengisa ye RAH.SG izabelo ze Recro Pharma, Inc. ngosuku lokugqibela lokurhweba lilinganiselwa kuma-0 €. Ixabiso lokuthengiswa kwezabelo ze Recro Pharma, Inc. latshintshile kwi-0% xa kuthelekiswa nosuku lwangaphambili lworhwebo.